Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

ISMPP EU

- PMLiVE

Virginia Acha leaves Amgen for ABPI

Joins UK pharma trade body as director of research, medical and innovation

Gilead Sciences

Gilead cuts hepatitis C drug prices in Germany

Discount on Sovaldi and Harvoni follows similar agreement in France

- PMLiVE

Indian generics firm GVK set to be hit with European sales ban

EU regulator raises concerns on conduct of drug studies in India

- PMLiVE

Samsung launches mobile app for autistic children

'Look At Me' aims to help children develop communications skills

- PMLiVE

Relief for Shire as FDA clears NPS’ Natpara

Drug was a key interest as part of NPS takeover

- PMLiVE

Grayling CEO Pete Pedersen resigns

He steps down after two years in role at Huntsworth company

- PMLiVE

Boehringer and Lilly sway NICE with new Jardiance data

Diabetes drug now backed to help glycaemic control in adults

- PMLiVE

Sharing the ‘chimp’ and its effect on decision-making

Pharma needs to learn how to dial up its emotional connectivity

- PMLiVE

GSK set ‘to cut 1,000 jobs’ in China

Pharma company's troubles in the country reportedly continue

EU flag

Antibiotics among 7 new drugs backed by EMA

The Medicines Company’s Orbactiv and Cubist’s Sivextro set for European approval

- PMLiVE

CHMP thumbs up for Novo’s obesity drug Saxenda

Diabetes drug liraglutide on course for new indication in EU

- PMLiVE

FDA panel backs new antifungal Cresemba

Basilea/Astellas drug tipped to become a $500m product

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links